Global Meloxicam Market Size study, by Diseases (Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Others) by Drug Type (Generic, Branded) by Population Type (Adult, Children) by Dosage (Oral, Parenteral, transdermal, Others) by Dose Strength (7.5mg, 15mg, Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028
- BIZ4950378
- 200 Pages
- March 2022
- Pharmaceuticals
The key regions considered for the global Meloxicam market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the dominating region across the world in terms of market share owing to the presence of rising population with arthritis & other chronic pain diseases, high healthcare expenditure and research & development. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as increased advancement in the technology as well as growing healthcare expenditure and rising awareness program would create lucrative growth prospects for the Meloxicam market across Asia-Pacific region.
Major market player included in this report are:
Taj Pharmaceutical Limited.
Wellona Pharma
Trumac Healthcare
Healthy Life Pharma Private Limited.
EPICON LIFESCIENCES LLP
Boehringer Ingelheim GmbH.
Baudax Bio
Viatris Inc.
Avanstra Inc.
PD-Rx Pharmaceuticals, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diseases:
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Others
By Drug Type:
Generic
Branded
By Population Type:
Adult
Children
By Dosage:
Oral
Parenteral
transdermal
Others
By Dose Strength:
7.5mg
15mg
Others
By End-Users:
Hospitals
Specialty Clinics
Home Healthcare
Others
By Distribution Channel:
Direct Tender
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Meloxicam Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Meloxicam Market, by Region, 2020-2028 (USD Billion)
1.2.2. Meloxicam Market, by Diseases, 2020-2028 (USD Billion)
1.2.3. Meloxicam Market, by Drug Type, 2020-2028 (USD Billion)
1.2.4. Meloxicam Market, by Population Type, 2020-2028 (USD Billion)
1.2.5. Meloxicam Market, by Dosage, 2020-2028 (USD Billion)
1.2.6. Meloxicam Market, by Dose Strength, 2020-2028 (USD Billion)
1.2.7. Meloxicam Market, by End-Users, 2020-2028 (USD Billion)
1.2.8. Meloxicam Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meloxicam Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meloxicam Market Dynamics
3.1. Meloxicam Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.2. Market Challenges
3.1.2.1. Rising preference of NSAIDs over other pain killers
3.1.3. Market Opportunities
3.1.3.1. Rising prevalence of chronic inflammatory and pain diseases
Chapter 4. Global Meloxicam Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Meloxicam Market, by Diseases
6.1. Market Snapshot
6.2. Global Meloxicam Market by Diseases, Performance - Potential Analysis
6.3. Global Meloxicam Market Estimates & Forecasts by Diseases 2019-2028 (USD Billion)
6.4. Meloxicam Market, Sub Segment Analysis
6.4.1. Osteoarthritis
6.4.2. Rheumatoid Arthritis
6.4.3. Juvenile Rheumatoid Arthritis
6.4.4. Others
Chapter 7. Global Meloxicam Market, by Drug Type
7.1. Market Snapshot
7.2. Global Meloxicam Market by Drug Type, Performance - Potential Analysis
7.3. Global Meloxicam Market Estimates & Forecasts by Drug Type 2019-2028 (USD Billion)
7.4. Meloxicam Market, Sub Segment Analysis
7.4.1. Generic
7.4.2. Branded
Chapter 8. Global Meloxicam Market, by Population Type
8.1. Market Snapshot
8.2. Global Meloxicam Market by Population Type, Performance - Potential Analysis
8.3. Global Meloxicam Market Estimates & Forecasts by Population Type 2019-2028 (USD Billion)
8.4. Meloxicam Market, Sub Segment Analysis
8.4.1. Adult
8.4.2. Children
Chapter 9. Global Meloxicam Market, by Dosage
9.1. Market Snapshot
9.2. Global Meloxicam Market by Dosage, Performance - Potential Analysis
9.3. Global Meloxicam Market Estimates & Forecasts by Dosage 2019-2028 (USD Billion)
9.4. Meloxicam Market, Sub Segment Analysis
9.4.1. Oral
9.4.2. Parenteral
9.4.3. transdermal
9.4.4. Others
Chapter 10. Global Meloxicam Market, by Dose Strength
10.1. Market Snapshot
10.2. Global Meloxicam Market by Dose Strength, Performance - Potential Analysis
10.3. Global Meloxicam Market Estimates & Forecasts by Dose Strength2019-2028 (USD Billion)
10.4. Meloxicam Market, Sub Segment Analysis
10.4.1. 7.5mg
10.4.2. 15mg
10.4.3. Others
Chapter 11. Global Meloxicam Market, by End-Users
11.1. Market Snapshot
11.2. Global Meloxicam Market by End-Users, Performance - Potential Analysis
11.3. Global Meloxicam Market Estimates & Forecasts by End-Users2019-2028 (USD Billion)
11.4. Meloxicam Market, Sub Segment Analysis
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Home Healthcare
11.4.4. Others
Chapter 12. Global Meloxicam Market, by Distribution Channel
12.1. Market Snapshot
12.2. Global Meloxicam Market by Distribution Channel, Performance - Potential Analysis
12.3. Global Meloxicam Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)
12.4. Meloxicam Market, Sub Segment Analysis
12.4.1. Direct Tender
12.4.2. Hospital Pharmacy
12.4.3. Retail Pharmacy
12.4.4. Online Pharmacy
12.4.5. Others
Chapter 13. Global Meloxicam Market, Regional Analysis
13.1. Meloxicam Market, Regional Market Snapshot
13.2. North America Meloxicam Market
13.2.1. U.S. Meloxicam Market
13.2.1.1. Diseases breakdown estimates & forecasts, 2019-2028
13.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2028
13.2.1.3. Population Type breakdown estimates & forecasts, 2019-2028
13.2.1.4. Dosage breakdown estimates & forecasts, 2019-2028
13.2.1.5. Dose Strength breakdown estimates & forecasts, 2019-2028
13.2.1.6. End-Users breakdown estimates & forecasts, 2019-2028
13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2019-2028
13.2.2. Canada Meloxicam Market
13.3. Europe Meloxicam Market Snapshot
13.3.1. U.K. Meloxicam Market
13.3.2. Germany Meloxicam Market
13.3.3. France Meloxicam Market
13.3.4. Spain Meloxicam Market
13.3.5. Italy Meloxicam Market
13.3.6. Rest of Europe Meloxicam Market
13.4. Asia-Pacific Meloxicam Market Snapshot
13.4.1. China Meloxicam Market
13.4.2. India Meloxicam Market
13.4.3. Japan Meloxicam Market
13.4.4. Australia Meloxicam Market
13.4.5. South Korea Meloxicam Market
13.4.6. Rest of Asia Pacific Meloxicam Market
13.5. Latin America Meloxicam Market Snapshot
13.5.1. Brazil Meloxicam Market
13.5.2. Mexico Meloxicam Market
13.6. Rest of The World Meloxicam Market
Chapter 14. Competitive Intelligence
14.1. Top Market Strategies
14.2. Company Profiles
14.2.1. Taj Pharmaceutical Limited.
14.2.1.1. Key Information
14.2.1.2. Overview
14.2.1.3. Financial (Subject to Data Availability)
14.2.1.4. Product Summary
14.2.1.5. Recent Developments
14.2.2. Wellona Pharma
14.2.3. Trumac Healthcare
14.2.4. Healthy Life Pharma Private Limited.
14.2.5. EPICON LIFESCIENCES LLP
14.2.6. Boehringer Ingelheim GmbH.
14.2.7. Baudax Bio
14.2.8. Viatris Inc.
14.2.9. Avanstra Inc.
14.2.10. PD-Rx Pharmaceuticals, Inc.
Chapter 15. Research Process
15.1. Research Process
15.1.1. Data Mining
15.1.2. Analysis
15.1.3. Market Estimation
15.1.4. Validation
15.1.5. Publishing
15.2. Research Attributes
15.3. Research Assumption
TABLE 1. Global Meloxicam Market, report scope
TABLE 2. Global Meloxicam Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Meloxicam Market estimates & forecasts by Diseases 2019-2028 (USD Billion)
TABLE 4. Global Meloxicam Market estimates & forecasts by Drug Type 2019-2028 (USD Billion)
TABLE 5. Global Meloxicam Market estimates & forecasts by Population Type 2019-2028 (USD Billion)
TABLE 6. Global Meloxicam Market estimates & forecasts by Dosage 2019-2028 (USD Billion)
TABLE 7. Global Meloxicam Market estimates & forecasts by Dose Strength 2019-2028 (USD Billion)
TABLE 8. Global Meloxicam Market estimates & forecasts by End-Users 2019-2028 (USD Billion)
TABLE 9. Global Meloxicam Market estimates & forecasts by Distribution Channel 2019-2028 (USD Billion)
TABLE 10. Global Meloxicam Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Meloxicam Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Meloxicam Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Meloxicam Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Meloxicam Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Meloxicam Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Meloxicam Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. Global Meloxicam Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. Global Meloxicam Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Global Meloxicam Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. U.S. Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. U.S. Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. U.S. Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. Canada Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. Canada Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Canada Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. UK Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. UK Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. UK Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. Germany Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. Germany Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. Germany Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. RoE Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. RoE Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. RoE Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. China Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. China Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. China Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. India Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. India Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. India Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. Japan Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. Japan Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Japan Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. RoAPAC Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. RoAPAC Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. RoAPAC Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Brazil Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Brazil Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Brazil Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. Mexico Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. Mexico Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Mexico Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. RoLA Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. RoLA Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. RoLA Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. Row Meloxicam Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 57. Row Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 58. Row Meloxicam Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 59. List of secondary sources, used in the study of global Meloxicam Market
TABLE 60. List of primary sources, used in the study of global Meloxicam Market
TABLE 61. Years considered for the study
TABLE 62. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
